The DOI matches its Crossref record.
Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.
Open accessAbstract
Blood samples from 125 unrelated families with classical type 2 neurofibromatosis (NF2) with bilateral vestibular schwannomas have been analysed for mutations in the NF2 gene. A further 17 families fulfilling modified criteria for NF2 have also been analysed. Causative mutations have been identified in 54 (43%) classical families and six (35%) of those fulfilling modified criteria. Forty-two cases from 38 families with truncating mutations had an average age at onset of symptoms of 19 years and diagnosis at 22.4 years. Fifty-one cases from 16 families with splice site mutations (15 from six), missense mutations (18 from six), and large deletions (18 from five) had an average age of onset of 27.8 years and at diagnosis of 33.4 years. Subjects with truncating mutations were significantly more likely to have symptoms before 20 years of age (p<0.001) and to develop at least two symptomatic CNS tumours in addition to vestibular schwannoma before 30 years (p<0.001). There were also significantly fewer multigenerational families with truncating mutations. Four further truncating mutations were in mosaic form and were associated with milder disease than other similar mutations. This large study has confirmed the previous impression that truncating mutations are associated with severe disease, but caution has to be exercised in using mutation type to predict disease course.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Asthagiri, A. R., Parry, D. M., Butman, J. A., Kim, H. J., Tsilou, E. T., Zhuang, Z., & Lonser, R. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60259-2 · Cited by 665
Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective
Ferner, R. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70075-3 · Cited by 511
Evans, D. G. R., Moran, A., King, A., Saeed, S., Gurusinghe, N., & Ramsden, R. (2005) · Otology & Neurotology · doi:10.1097/00129492-200501000-00016 · Cited by 418
Self-citationTyburczy, M. E., Dies, K. A., Glass, J., Camposano, S., Chekaluk, Y., Thorner, A. R., Lin, L., Krueger, D., Franz, D. N., Thiele, E. A., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005637 · Cited by 298
Management of the patient and family with neurofibromatosis 2: a consensus conference statement
Evans, D., Baser, M., O'Reilly, B., Rowe, J., Gleeson, M., Saeed, S., King, A., Huson, S., Kerr, R., Thomas, N., et al. (2005) · British Journal of Neurosurgery · doi:10.1080/02688690500081206 · Cited by 261
Self-citation
Metadata
- Authors
- Evans, D. G., Trueman, L., Wallace, A., Collins, S., & Strachan, T.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 1998-06
- Volume
- 35
- Issue
- 6
- Pages
- 450-455
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2169067763
- Cited by
- 224
- References
- 0
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. https://app.cochat.ai/papers/10.1136/jmg.35.6.450
- The paper
- Evans, D. G., Trueman, L., Wallace, A., Collins, S., & Strachan, T. (1998). Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. Journal of Medical Genetics. https://doi.org/10.1136/jmg.35.6.450
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.